Home > Reading Room > Cobalt and GlaxoSmithKline Finally Reach Settlement

Cobalt and GlaxoSmithKline Finally Reach Settlement

Written by Riyaz Jariwalla on 26 February 2007

« Return to Reading Room

It was announced on 15 November 2006 that Cobalt Laboratories Inc. has reached a patent litigation settlement with GlaxoSmithKline Plc. regarding its ‘sumatriptan succinate tablets’, the generic version of GlaxoSmithKline's Imitrex, which is sold to treat migraine pain.

Cobalt Pharmaceuticals Inc. announced in a statement that the company may distribute a generic version in the U.S. by the first quarter of 2009 following the settlement which remains subject to government review.

This was just one term that was agreed between lawyers, but the statement did not provide additional details on the other terms of the settlement.

If you'd like to know more about this article please send an email to Unknown quoting the article title and any questions you might have, alternatively call the office number on 02380 235 979 or send an enquiry through our contact form.

Want to speak
to someone?

Complete the form below and we’ll call you back free of charge.

Visual Captcha